Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Marriott

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
Therapeutic Drug Monitoring|October 15, 2021
Therapeutic Drug Monitoring of the Echinocandin Antifungal Agents: Is There a Role in Clinical Practice? A Position Statement of the Anti-Infective Drugs Committee of the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyHannah Yejin Kim, Sara Baldelli, Anne-Grete Märtson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 7, 2026
Impact of early locus coeruleus lesions in the TgF344 Alzheimer's disease rat modelAlexia E Marriott, Jason P Schroeder, Anu Korukonda, et al.
British Journal of Clinical Pharmacology|July 22, 2020
Would they trust it? An exploration of psychosocial and environmental factors affecting prescriber acceptance of computerised dose-recommendation softwareJane E Carland, Tania Elhage, Melissa T Baysari, et al.
Journal of Medical Virology|February 1, 1995
Hepatitis B and D genomes in hepatitis B surface antigen negative patients with chronic hepatitis CS González, S Navas, A Madejón, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 11, 1992
Hepatitis C--importance of screening the organ donor preoperativelyD R Schuch, P B Kelly, M T Ingram, et al.
Scientific Reports|April 14, 2018
Validation of ultrasound bioimaging to predict worm burden and treatment efficacy in preclinical filariasis drug screening modelsAmy E Marriott, Hanna Sjoberg, Hayley Tyrer, et al.
British Journal of Clinical Pharmacology|September 4, 2020
Evaluation of amikacin use and comparison of the models implemented in two Bayesian forecasting software packages to guide dosingAlice C Ryan, Jane E Carland, Robert C McLeay, et al.
Clinical Pharmacology and Therapeutics|September 30, 2020
A Model Averaging/Selection Approach Improves the Predictive Performance of Model-Informed Precision Dosing: Vancomycin as a Case StudyDavid W Uster, Sophie L Stocker, Jane E Carland, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 27, 2021
Current fluconazole treatment regimens result in under-dosing of critically ill adults during early therapyIndy Sandaradura, Deborah J E Marriott, Richard O Day, et al.
American Journal of Obstetrics and Gynecology|July 4, 2014
Adherence to the 2012 national cervical cancer screening guidelines: a pilot studyDeanna G K Teoh, Amity E Marriott, Rachel Isaksson Vogel, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Therapeutic Drug Monitoring|October 15, 2021
Therapeutic Drug Monitoring of the Echinocandin Antifungal Agents: Is There a Role in Clinical Practice? A Position Statement of the Anti-Infective Drugs Committee of the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyHannah Yejin Kim, Sara Baldelli, Anne-Grete Märtson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 7, 2026
Impact of early locus coeruleus lesions in the TgF344 Alzheimer's disease rat modelAlexia E Marriott, Jason P Schroeder, Anu Korukonda, et al.
British Journal of Clinical Pharmacology|July 22, 2020
Would they trust it? An exploration of psychosocial and environmental factors affecting prescriber acceptance of computerised dose-recommendation softwareJane E Carland, Tania Elhage, Melissa T Baysari, et al.
Journal of Medical Virology|February 1, 1995
Hepatitis B and D genomes in hepatitis B surface antigen negative patients with chronic hepatitis CS González, S Navas, A Madejón, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 11, 1992
Hepatitis C--importance of screening the organ donor preoperativelyD R Schuch, P B Kelly, M T Ingram, et al.
Scientific Reports|April 14, 2018
Validation of ultrasound bioimaging to predict worm burden and treatment efficacy in preclinical filariasis drug screening modelsAmy E Marriott, Hanna Sjoberg, Hayley Tyrer, et al.
British Journal of Clinical Pharmacology|September 4, 2020
Evaluation of amikacin use and comparison of the models implemented in two Bayesian forecasting software packages to guide dosingAlice C Ryan, Jane E Carland, Robert C McLeay, et al.
Clinical Pharmacology and Therapeutics|September 30, 2020
A Model Averaging/Selection Approach Improves the Predictive Performance of Model-Informed Precision Dosing: Vancomycin as a Case StudyDavid W Uster, Sophie L Stocker, Jane E Carland, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 27, 2021
Current fluconazole treatment regimens result in under-dosing of critically ill adults during early therapyIndy Sandaradura, Deborah J E Marriott, Richard O Day, et al.
American Journal of Obstetrics and Gynecology|July 4, 2014
Adherence to the 2012 national cervical cancer screening guidelines: a pilot studyDeanna G K Teoh, Amity E Marriott, Rachel Isaksson Vogel, et al.
Pageof 10